Aims and objectives

The ESCMID Study Group for Implant-Associated Infections (ESGIAI) focuses on the challenges posed by implant-associated infections in clinical microbiology (CM) and infectious diseases (ID). Through a multidisciplinary approach, ESGIAI is committed to:

  • Navigating the complexities of unresolved clinical and diagnostic challenges
  • Improving the management of patients and the possibility to cure these infections

Activities and resources

Come and join our upcoming Postgraduate Education Course

Implant infections: focus on prosthetic joint and fracture-related infections

05 -06 October 2026, online

Go to course website

ESGIAI Newsletter, July 2026

Download


ESGIAI Newsletter, May 2026

Download


ESGIAI Newsletter, February 2026

Download


ESGIAI Newsletter, December 2025

Download


ESGIAI Newsletter, November 2025

Download


ESGIAI Newsletter, September 2025

Download


ESGIAI Newsletter, July 2025

Download


ESGIAI Newsletter, June 2025

Download

and the ESGIAI project proposal form

Download


ESGIAI Newsletter, February 2025

Download

Global practice variation of suppressive antimicrobial treatment for prosthetic joint infections: A cross-sectional survey study. 

Hanssen JLJ, Gademan MGJ, Wouthuyzen-Bakker M, Davis JS, Dewar D, Manning L, Campbell D, van Prehn J, Miller AO, van der Wal RJP, van der Linden HMJ, Cortés-Penfield NW, Soriano A, de Boer MGJ, Scheper H. J Infect. 2024 Dec;89(6):106316

Go to publication


Risk Factors for Discordance Between Synovial Fluid Culture and Intraoperative Cultures in Revision Arthroplasties: Results From a European Multicentre Observational Study. 

Ottink KD, Olearo F, Vaznaisiene D, Rolvien T, Kaoual S, Morreel E, Bîrluţiu V, Gómez-Junyent J, Lindberg-Larsen M, Reissier S, Rossi N, Dolores Del Toro Lopez M, Widerström M, Fernandez Sampedro M, Veltman ES, Petersdorf S, Rohde H, Wouthuyzen-Bakker M. JB JS Open Access. 2026 Apr 14;11(2):e26.00067

Go to publication


Best microbiological practice recommendations for the diagnosis of peri-prosthetic joint infections: the CRIOGO bacteriology reference center network.

Bémer P, Plouzeau-Jayle C, Lemarié C, Tande D, Gougeon-Jolivet A, Chenouard R, Lamoureux C, Reissier S, Ruffier d'Epenoux L, Chaufour L, Lartigue MF, Corvec S; on behalf the CRIOGO study group.  Ann Clin Microbiol Antimicrob. 2025 Nov 4;24(1):61

Go to publication


In vitro emergence of amoxicillin-resistance and impact of amoxicillin on biofilm production across Cutibacterium acnes phylotypes? 

Ruffier d'Epenoux L, Rwayane K, Paquin A, Persyn E, Fayoux E, Hervochon C, Corvec S. Eur J Clin Microbiol Infect Dis. 2026 Apr;45(4):1213-1218. doi: 10.1007/s10096-025-05359-3. Epub 2026 Jan 4. Erratum in: Eur J Clin Microbiol Infect Dis. 2026 Apr;45(4):1219

Go to publication


Geographical Differences in the Epidemiology and Treatment of Candida Prosthetic Joint Infections. 

Mamona-Kilu C, Lora-Tamayo J, McNally M, Duran C, Ho R, Scarborough M, Dudareva M, Bonnet E, Escolà-Vergé L, Pardo DR, Jesuthasan G, Senneville E, Thill P, Klein S, Ronde-Oustau C, Redó MLS, Corvec S, Rossi N, Esteban J, Lemaignen A, Ribeiro TC, Mazet J, Sasso M, Costa Salles MJ, Mancheño-Losa M, Giordano G, Frank BJH, Hofstaetter JG, Allende JMB, Lortholary O, Fourcade C, Morata L, Soriano A, Dinh A; European Society of Clinical Microbiology and Infectious Diseases Study Group on Implant Associated Infections (ESGIAI). Open Forum Infect Dis. 2026 Apr 15;13(4):ofag208

Go to publication


How to manage patients receiving long-term suppressive antibiotic treatment for infective endocarditis: the role of [18F]-FDG-PET/CT imaging - An international multidisciplinary survey. 

Pascale R, Fernández-Hidalgo N, Tazza B, Bartoletti M, Bertolino L, Durante-Mangoni E, Pérez AR, Pizzi MN, Viale P, Giannella M; European Society of Clinical Microbiology and Infectious Diseases Study Group on Implant Associated Infections (ESGIAI); European Society of Clinical Microbiology and Infectious Diseases Study Group for Bloodstream Infections, Endocarditis and Sepsis (ESGBIES). J Nucl Cardiol. 2025 Sep 27:102505

Go to publication


Bacterial skin colonization with a specific Cutibacterium avidum clade as a risk factor for periprosthetic joint infections—a multicenter study. 

Salar Vidal L, Prinz J, Frey PM, Schweizer TA, Böni L, Brugger SD, Brüggemann H, Esteban J, Achermann Y, . 0. Microbiol Spectr 0:e00515-25.

Go to publication


Diagnostic accuracy of 16S rDNA PCR, multiplex PCR and metagenomic next-generation sequencing in periprosthetic joint infections: a systematic review and meta-analysis.  

Olearo F, Zein SE, Portillo ME, Zapf A, Rohde H, Berbari EF, Wouthuyzen-Bakker M; ESCMID study group on implant-associated infections (ESGIAI) and the molecular working group for the unified PJI definition task force. Clin Microbiol Infect. 2025 Jul;31(7):1115-1125

Go to publication


Risk factors for treatment failure in late acute periprosthetic joint infection in patients with rheumatoid arthritis treated with surgical debridement - a case-control study.

Schenk HM, Sebillotte M, Lomas J, Taylor A, Benavent E, Murillo O, Fernandez-Sampedro M, Huotari K, Aboltins C, Trebse R, Soriano A, Wouthuyzen-Bakker M; ESCMID Study Group on Implant Associated Infections (ESGIAI).  J Bone Jt Infect. 2025 Jul 14;10(4):217-224

Go to publication


Prosthetic Joint Infections due to Candida Species: A Multicenter International Study.

Dinh A, McNally M, D'Anglejan E, Mamona Kilu C, Lourtet J, Ho R, Scarborough M, Dudareva M, Jesuthasan G, Ronde Oustau C, Klein S, Escolà-Vergé L, Rodriguez Pardo D, Delobel P, Lora-Tamayo J, Mancheño-Losa M, Sorlí Redó ML, Barbero Allende JM, Arvieux C, Vaznaisiène D, Bauer T, Roux AL, Noussair L, Corvec S, Fernández-Sampedro M, Rossi N, Lemaignen A, Costa Salles MJ, Cunha Ribeiro T, Mazet J, Sasso M, Lavigne JP, Sotto A, Canouï E, Senneville É, Thill P, Lortholary O, Lanternier F, Morata L, Soriano A, Giordano G, Fourcade C, Frank BJH, Hofstaetter JG, Duran C, Bonnet E; European Society of Clinical Microbiology and Infectious Diseases Study Group on Implant Associated Infections (ESGIAI). Prosthetic Joint Infections due to Candida Species: A Multicenter International Study. Clin Infect Dis. 2025 Feb 24;80(2):347-355

Go to publication


Treatment and Follow-up of Vascular Graft and Endograft Infection: Delphi Consensus Document.  

Kouijzer, I. J. E., Hernández-Meneses, M., Aarntzen, E. H. J. G., Ahl, J., Baddour, L. M., DeSimone, D. C., Durante Mangoni, E., Fernández-Hidalgo, N., Geuzebroek, G. S. C., Giannitsioti, E., Glaudemans, A. W. J. M., Husmann, L., Merli, M., Mestres, C. A., Olearo, F., Papadimitriou-Olivgeris, M., Jørgensen, N. P., Perissinotti, A., Raglio, A., ... Hasse, B. (2025). Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Go to publication


Prosthetic Joint Infections due to Candida Species: A Multicenter International Study. 

Dinh A, McNally M, D'Anglejan E, Mamona Kilu C, Lourtet J, Ho R, Scarborough M, Dudareva M, Jesuthasan G, Ronde Oustau C, Klein S, Escolà-Vergé L, Rodriguez Pardo D, Delobel P, Lora-Tamayo J, Mancheño-Losa M, Sorlí Redó ML, Barbero Allende JM, Arvieux C, Vaznaisiène D, Bauer T, Roux AL, Noussair L, Corvec S, Fernández-Sampedro M, Rossi N, Lemaignen A, Costa Salles MJ, Cunha Ribeiro T, Mazet J, Sasso M, Lavigne JP, Sotto A, Canouï E, Senneville É, Thill P, Lortholary O, Lanternier F, Morata L, Soriano A, Giordano G, Fourcade C, Franck BJH, Hofstätter JG, Duran C, Bonnet E; European Society of Clinical Microbiology and Infectious Diseases Study Group on Implant Associated Infections (ESGIAI). Clin Infect Dis. 2024 Aug 27:ciae395

Go to publication


Prosthetic Joint Infections Caused by Mycobacterium tuberculosis Complex-An ESGIAI-ESGMYC Multicenter, Retrospective Study and Literature Review.

Auñon A, Salar-Vidal L, Mahillo-Fernandez I, Almeida F, Pereira P, Lora-Tamayo J, Ferry T, Souèges S, Dinh A, Escudero R, Menéndez Fernández-Miranda C, Rico A, Rossi N, Esteban J. Microorganisms. 2024 Apr 24;12(5):849

Go to publication


Is an isolated positive sonication fluid culture in revision arthroplasties clinically relevant?

Rondaan C, Maso A, Birlutiu RM, Fernandez Sampedro M, Soriano A, Diaz de Brito V, Gómez Junyent J,Del Toro MD, Hofstaetter JG, Salles MJ, Esteban J, Wouthuyzen-Bakker M; ESCMID Study Group on Implant-Associated Infections (ESGIAI). Clin Microbiol Infect. 2023;S1198-743X(23)00345-2.

Go to publication


Risk factors for Gram-negative bacterial infection of cardiovascular implantable electronic devices: multicentre observational study (CarDINe Study)

Pascale R, Toschi A, Aslan AT, Massaro G, Maccaro A, Fabbricatore D, Dell'Aquila A, Ripa M, Işık ME,Kızmaz YU, Iacopino S, Camici M, Perna F, Akinosoglou K, Karruli A, Papadimitriou-Olivgeris M,Kayaaslan B, Bilir YA, Evren Özcan E, Turan OE, Işık MC, Pérez-Rodríguez MT, Yagüe BL, Quirós AM,Yılmaz M, Petersdorf S, De Potter T, Durante-Mangoni E, Akova M, Curnis A, Gibertoni D, DiembergerI, Scudeller L, Viale P, Giannella M; CarDINe Study Group. International Journal of Antimicrobial Agents. 2023;61(3):106734.

Go to publication


Should we use rifampicin in periprosthetic joint infections caused by Staphylococci when the implant has been exchanged? A multicenter observational cohort study.

Kramer TS, Soriano A, Tedeschi S, Chen AF, Tattevin P, Senneville E, Gomez-Junyent J, Birlutiu V,Petersdorf S, de Brito VD, Gonzalez IS, Belden KA, Wouthuyzen-Bakker M, on behalf of the ESCMID Study Group on Implant Associated Infections (ESGIAI). Open Forum Infectious Diseases. 2023;10(10):ofad491.

Go to publication

30

Sep 26
30 September 2026, 13:00 CEST
Webinar

10

Jun 26
10 June 2026, 11:15 CEST
Online
Webinar

11

Dec 25
11 December 2025, 16:00 CET
Webinar

This page gives an overview of our planned and ongoing ESGIAI research projects.

Information how to join projects which are currently recruiting can be found at the bottom of the respective section.

 

DESIRE: Invitation to Participate in a Study on Dalbavancin as Suppressive Antibiotic Treatment

We are pleased to invite you to participate in a study investigating the use of Dalbavancin as suppressive antibiotic treatment. This is a retrospective, multicenter study supported by ESGIAI and endorsed by ESGIE groups from ESCMID. It focuses on all cases where Dalbavancin has been used as suppressive antibiotic treatment, apart from its original indication.
 

Scientific Committee:

  • Victor Ichbia, Resident, ID Specialist
  • Aurélien Dinh, ID Specialist (ESGIAI member)
  • Eric Senneville, ID Specialist (ESCMID member)
  • Claire Roubaud, Geriatrician (ESGIE member)
  • Clara Duran, Clinical Research Assistant

Factors associated with infections by Multidrug-Resistant Pathogens in Neurosurgical Implants: A multicenter Retrospective Cohort Study

Primary Objective: To determine the prevalence of MDR pathogen infections in patients with neurosurgical implant-related infections

Secondary Objectives:

  • To describe  the demographic/clinical characteristics and microbiology of patients with neurosurgical implant-related infections
  • To identify risk factors associated with the development of MDR infections in these patients
  • To describe and compare the effectiveness of different treatment strategies (antimicrobial therapy, surgical intervention) in patients with and without MDR neurosurgical implants related infections
  • To assess and compare the impact of of MDR vs. non-MDR infections on clinical  outcomes, including morbidity, mortality, and length of hospital stay

Lydia Leonidou, Efthymia Giannitsioti 


PJI due Enterobacterales C3G resistant International retrospective multicentric study

Aim: Describe epidemiology, clinical presentation, treatment and outcome of PJI due to 3rdGC-resistant Enterobacterales

Scentific group

  • Aurélien Dinh
  • Jaime Lora Tamayo
  • Martin Mc Nally
  • Johan Courjon
  • Eric Senneville
  • Maria Durdareva
  • on behalf of the European Society of Clinical Microbiology and Infectious Diseases Study Group of Implant Associated Infections (ESGIAI).

More information on the projects which are currently recruiting

Download

Last update: 14 July 2026

The Outcome of Surgical Debridement and Implant Retention in Patients With Periprosthetic Joint Infection of a Mega Prosthesis

Aims:

  • To describe the clinical outcome of a DAIR procedure in patients with a PJI of a megaprosthesis of the hip or knee. 
  • To describe patient, implant and surgery-related risk factors for DAIR failure in patients with a PJI of a megaprosthesis (specific focus on antiseptic solutions, surface characteristics, component exchange)

Principal Investigator. Marjan Wouthuyzen-Bakker (ESGIAI member)


A Unified Definition of Periprosthetic Joint Infection: EBJIS, ESGIAI, ICM, IDSA, MSIS

Principal Investigator: Marjan Wouthuyzen-Bakker 

Methods

  • Recommendation about the position of the diagnostic test in the unified PJI definition
  • Recommendation about the position of the diagnostic test in the diagnostic flowchart of a patient with suspected PJI 
  • Recommendations basic principles
  • Recommendations were entered into an anonymous Delphi round

Publication expected soon


Evaluation of the risk of treatment failure in patients with fracture related infection.  Multicenter study and proposal for a Fracture Related Infection Management ALgorithm (FRIMAL protocol).

Principal Investigators: María Dolores del Toro, Bouchra Dahiri, Raquel García Albea

Background: Management of FRI based on low-quality studies and expert opinion, more evidence is needed to support the medical-surgical management of these infections 

Objectives

  • To identify risk factors associated with DAIR failure in early and delayed FRI, and to develop a risk-scoring systems.
  • To compare the clinical outcome of patients with early and delayed FRI treated with DAIR or immediate implant removal.
  • To identify those patients who may benefit more from implant removal instead of DAIR.

CAPJI: Current aetiology of joint prosthesis infections. How does it influence the empirical treatment of infections and the surgical prophylaxis of joint prosthesis implantation?

Principal Investigators: Anna Gallego, Natividad Benito

Objectives

  • Current epidemiology of PJIs / differences geographical areas
  • Risk factors of antimicrobial resistant PJIs
  • Specific MDROs
  • SAP (cefazolin) resistance – postoperative PJIs
  • Empiric treatments (PJIs) & SAP (arthroplasty surgery) tailored to individual patient risks

Longterm antibiotic therapy in non-surgical prosthetic valve endocarditis. L-TAPE study

Principle investigators: Renato Pascale, Linda Bussini, Michele Bartoletti, Natascia Caroccia

Design: Retrospective, international, multicenter study

Population: All adult patients with diagnosis of definitive or possible left-sided PVE (Duke criteria) including TAVI-PVE not eligible for surgery during the period 2013-2025. Patients must have already received at least 4 weeks of standard treatment for PVE according to guidelines. 

Definition: LTAT is defined as treatment for endocarditis lasting ≥6 weeks. 

Primary endpoint: Composite outcome of death, relapse of positive blood cultures for index pathogen, septic embolization, heart failure at 360 days from PVE diagnosis.


Anaerobic PJI - narrative review of the microbiological aspects

Principal investigators. Holger Rohde, Elizabeth Moreel, Eugenia Portillio, Flaminia Olearo


Should antimicrobial prophylaxis in arthroplasty surgery be adapted for patients at high risk of resistant pathogens

Principal investigators. Natividad Benito, Corian Sadelier Francisco Almeida, Alessandro Russo, Rares Birlutiu
 

Executive Committee

  Efthymia Giannitsioti

Efthymia Giannitsioti

Chair
LAIKO General Hospital. 1st Department of Propaedeutic and Internal Medicine, Medical School National and Kapodistrian University.
Athens, Greece
  Barbara Hasse

Barbara Hasse

Science Officer
Infectious Diseases and Hospital Epidemiology
Zurich, Switzerland
  Andrej Trampuz

Andrej Trampuz

Education Officer
Queensland University of Technology, QIMR-Berghofer Medical Research Institute
Brisbane, Australia
  Maria Dolores Del Toro

Maria Dolores Del Toro

Secretary
Hospital Universitario Virgen Macarena
Seville, Spain

Contact

If you have questions or comments for our study group, we warmly invite you to contact us!

Contact form